Peer-reviewedPublisher termsEuropean Heart Journal. Acute Cardiovascular Care
Inflammation in cardiogenic shock: a marker of outcome, not yet a treatment target
Related
- Discovery of a potent covalent inhibitor for the treatment of sepsis targeting DNAJC9: Identification of a druggable target for inflammation.
- Age and Sex Influence the Neutrophil-to-Lymphocyte Ratio (NLR), a Systemic Inflammation Marker.
- The Aldosterone–Immune Axis in Primary Aldosteronism: Linking Adrenal Pathogenesis to Systemic Inflammation and Target-Organ Damage
- Advanced Lung Cancer Inflammation Index as a Prognostic Inflammation–Nutrition Marker in Appendiceal High‐Grade Pseudomyxoma Peritonei: A 10‐Year Single‐Center Study
- A multidimensional proteomic framework of circulating inflammation identifies outcome-specific cardiovascular risk axes in 39,494 UK biobank participants
BibTeX
@article{guzik2026inflammation,
title = {{Inflammation in cardiogenic shock: a marker of outcome, not yet a treatment target}},
author = {Tomasz J Guzik},
journal = {European Heart Journal. Acute Cardiovascular Care},
year = {2026},
month = oct,
doi = {10.1093/ehjacc/zuag124},
url = {https://doi.org/10.1093/ehjacc/zuag124},
}
RIS
TY - JOUR
TI - Inflammation in cardiogenic shock: a marker of outcome, not yet a treatment target
AU - Tomasz J Guzik
PY - 2026
DA - 2026/10/19
JO - European Heart Journal. Acute Cardiovascular Care
DO - 10.1093/ehjacc/zuag124
UR - https://doi.org/10.1093/ehjacc/zuag124
SN - 2048-8726
SN - 2048-8734
ER -